Orca Bio
Clinical trials sponsored by Orca Bio, explained in plain language.
-
Second-Chance stem cell therapy for blood cancer patients
Disease control Expanded accessThis program gives patients with certain blood cancers access to Orca-T, a donor stem cell therapy, when the commercial version cannot be used. It is for people who have no other treatment options. The program monitors safety but does not test if the therapy works.
Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated Sep 21, 2026 14:00 UTC
-
New cell therapy aims to make stem cell transplants safer for blood cancer patients
Disease control Recruiting nowThis phase 2 trial is testing a new treatment called Orca-T for people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Orca-T is a personalized cell therapy made from a donor's blood that includes stem cells and immune cells. The goal is to see if it can impr…
Phase 2 • Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Engineered donor cells aim to make stem cell transplants safer for blood cancer patients
Disease control Recruiting nowThis study tests a new way to prepare donor stem cells (called Orca-Q) for people with blood cancers like leukemia or MDS who need a transplant. The goal is to see if this engineered graft is safe and helps the body accept the new cells with fewer complications. About 300 partici…
Phase 1 • Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC